Status:
COMPLETED
Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)
Lead Sponsor:
Amgen
Conditions:
Lung Cancer
Non-Small Cell Lung Cancer
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of this research study is to evaluate the safety and effectiveness of Neulasta® (pegfilgrastim) in reducing infection when given on the same day versus one day after the completion of chem...
Eligibility Criteria
Inclusion
- Eligibility Criteria: - Age 18 years or older - Diagnosis of advanced or metastatic non-small cell lung cancer (NSCLC) - Have not received any prior chemotherapy - Have not received radiation therapy or undergone major surgery within the past 2 weeks
Exclusion
Key Trial Info
Start Date :
July 1 2003
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
February 1 2006
Estimated Enrollment :
90 Patients enrolled
Trial Details
Trial ID
NCT00094822
Start Date
July 1 2003
End Date
February 1 2006
Last Update
February 13 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.